Effect of season and ambient temperature on outcome of guaiac-based faecal occult blood tests performed for colorectal cancer screening

Colorectal Disease

Volumn 14, Issue 9, 2012, Pages 1084-1089

  Hunter, J P ^a   Saratzis, A ^b   Froggatt, P ^c   Harmston, C ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GEORGE ELIOT HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

Colorectal cancer; Faecal occult blood test; Screening; Season

Indexed keywords

ADULT; ARTICLE; AUTUMN; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; ENVIRONMENTAL TEMPERATURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METEOROLOGY; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; SPRING; SUMMER; WINTER;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GUAIAC; HUMANS; INDICATORS AND REAGENTS; MALE; MIDDLE AGED; OCCULT BLOOD; REPRODUCIBILITY OF RESULTS; SEASONS; TEMPERATURE; WEATHER;

EID: 84865410909     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02900.x     Document Type: Article

References (26)

1. Eddy DM. The economics of cancer prevention and detection: getting more for less. Cancer 1981; 47: 1200-9.
2. Schwartz S, Dahl J, Ellefson M, Ahlquist D. The 'HemoQuant' test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials. Clin Chem 1983; 29: 2061-7.
3. Vilkin A, Rozen P, Levi Z et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 2005; 100: 2519-25.
4. Steele RJ, McClements PL, Libby G et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009; 58: 530-5.
5. Burch JA, Soares-Weiser K, John DJ St et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 2007; 14: 132-7.
6. Steele RJ, Parker R, Patnick J et al. A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J Med Screen 2001; 8: 197-202.
7. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
8. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
9. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71.
10. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008; 95: 1029-36.
11. Whynes DK, Mangham CM, Balfour TW, Scholefield JH. Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer. Gut 2010; 59: 1088-93.
12. Logan RF. Review: faecal occult blood test screening reduces risk of colorectal cancer mortality. Evid Based Med 2009; 14: 15.
13. Young GP, St John DJ, Winawer SJ, Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: Recommendations based on performance characteristics in population studies: A WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002; 97: 2499-507.
14. van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135: 82-90.
15. Guittet L, Bouvier V, Mariotte N et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007; 56: 210-4.
16. Young GP, Sinatra MA, St John DJ. Influence of delay in stool sampling on fecal occult blood test sensitivity. Clin Chem 1996; 42: 1107-8.
17. Faure H, Exbrayat C, Winckel P, Bolla M. Moisture content of Hemoccult slides influences test sensitivity. Eur J Gastroenterol Hepatol 2003; 15: 1111-4.
18. Grazzini G, Ventura L, Zappa M et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut 2010; 59: 1511-5.
19. Laatikainen T, Dunbar JA, Chapman A et al. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health 2007; 7: 249.
20. Guittet L, Guillaume E, Levillain R et al. Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2011; 20: 1492-501.
21. Rose IS, Young GP, St John DJ, Deacon MC, Blake D, Henderson RW. Effect of ingestion of hemoproteins on fecal excretion of hemes and porphyrins. Clin Chem 1989; 35: 2290-6.
22. McDonald CA, Burford Y, Yuen AC, Walls RS, Goulston KJ. Immunochemical detection of fecal occult blood. Aust N Z J Med 1984; 14: 105-10.
23. Davies PS, Bates CJ, Cole TJ, Prentice A, Clarke PC. Vitamin D: seasonal and regional differences in preschool children in Great Britain. Eur J Clin Nutr 1999; 53: 195-8.
24. Metzger KB, Ito K, Matte TD. Summer heat and mortality in New York City: how hot is too hot? Environ Health Perspect 2010; 118: 80-6.
25. Sebok MA, Notari EP, Chambers LA, Benjamin RJ, Eder AF. Seasonal temperature variation and the rate of donor deferral for low hematocrit in the American Red Cross. Transfusion 2007; 47: 890-4.
26. Wang XY, Barnett AG, Hu W, Tong S. Temperature variation and emergency hospital admissions for stroke in Brisbane, Australia, 1996-2005. Int J Biometeorol 2009; 53: 535-41.